Atlas Trials

Study of AT-752 in Patients With Dengue Infection

Clinical trial NCT05466240 · TERMINATED

Trial details

NCT number
NCT05466240
Sponsor
Atea Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Dengue Fever
Start date
2022-04-29
Primary completion
2023-01-19
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.